MeSH Browser

MeSH Heading: Fluticasone-Salmeterol Drug Combination
Tree Number(s): D02.033.100.291.057.750.500; D02.092.063.291.057.750.500; D02.092.471.683.061.750.500; D04.210.500.054.079.129.114.500; D26.310.438
Unique ID: D000068297
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000068297
Scope Note: A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
Entry Term(s): Advair; Advair Diskus; Advair HFA; Fluticasone - Salmeterol; Fluticasone Propionate - Salmeterol; Fluticasone Propionate - Salmeterol Combination; Fluticasone Propionate - Salmeterol Xinafoate; Fluticasone Propionate, Salmeterol Xinafoate Drug Combination; Fluticasone Propionate-Salmeterol Drug Combination; Fluticasone Propionate-Salmeterol Xinafoate Combination; Fluticasone Propionate-Salmeterol Xinafoate Drug Combination; Fluticasone-Salmeterol Combination; Seretide
Pharm Action: Bronchodilator Agents
Glucocorticoids
Sympathomimetics
Registry Number: 0
Public MeSH Note: 2016; FLUTICASONE PROPRIONATE-SALMETEROL XINAFOATE DRUG COMBINATION was indexed under ALBUTEROL 2001-2015; and under ANDROSTADIENES 2001-2015.
History Note: 2016 (2001)
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2017/01/17

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Fluticasone-Salmeterol Drug Combination MeSH Descriptor Data 2023